Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 9Genitourinary 5Thoracic 3Plasma cell 3Head & Neck 3Gastrointestinal 3Lymphoid 2Tumor-Agnostic 1Other neoplasm 1Other hematologic neoplasm 1Other 1Gynecologic 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Rituximab 689Cyclophosphamide 615Vincristine 285Etoposide 272Doxorubicin 271Cytarabine 230Prednisone 229Methotrexate 221fludarabine phosphate 189Filgrastim 187Dexamethasone 180fludarabine 176Lenalidomide 165Radiotherapy 128Melphalan 127Peripheral Blood Stem Cell Transplantation 123Busulfan 118Bendamustine Hydrochloride 116Granulocyte Colony-Stimulating Factor 113Bortezomib 112ibrutinib 111Mycophenolic Acid 110venetoclax 106Whole-Body Irradiation 106obinutuzumab 105Tacrolimus 105Gemcitabine 92zanubrutinib 81Specimen Handling 80Cyclosporine 76

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Sugars × Lymphoid × Clear all
NCT01988571 2022-01-04

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Wake Forest University Health Sciences

Phase 2 Completed
279 enrolled 26 charts
BreastLymphoid

Breast Neoplasms, Lymphoma

NCT01733953 2016-12-14

Statin Therapy in Young Adult Survivors of Childhood Cancer

University of Minnesota

Phase 2 Completed
27 enrolled 11 charts
LymphoidOther hematologic neoplasm

Cardiovascular Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡